Unlocking Innovation: New Models And Next-Gen Tech For Success

At the Pharma 2025 conference in Barcelona, industry experts highlighted how artificial intelligence and digital innovation are reshaping the pharmaceutical landscape. Leaders from AstraZeneca and Cencora discussed how AI is already impacting the industry, from accelerating content creation and streamlining regulatory processes to leveraging multimodal data to predict patient outcomes. The conversation underscored the importance of patient-centricity, emphasizing the need for personalized care and timely, useful information for stakeholders. It also addressed key challenges, such as ensuring that digital pilots are scalable and that the value of innovations is properly measured.

This discussion painted a clear picture of an industry that is both excited by the potential of new technologies and committed to using them to improve patient outcomes and drive commercial success.